secwatch.observer — SEC 8-K summary
======================================

Issuer:     Altimmune, Inc. (ALT)
CIK:        0001326190
Form:       8-K
Filed at:   2025-09-25T23:59:59+00:00
Accession:  0001326190-25-000050
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Altimmune shareholders elect all 10 director nominees; say-on-pay passes
------------------------------------------------------------------------

- All 10 director nominees elected; Jerome Durso received highest "for" votes (20.6M), Philip Hodges lowest (14.7M).
- Say-on-pay proposal passed with 14.9M for (68.2%), 6.7M against (30.6%), and 267K abstentions.
- Ratification of Ernst & Young as FY2025 auditor passed with 48.9M for, 1.4M against, 1.4M abstain.
- Broker non-votes on director elections and say-on-pay totaled 29.9M shares (58% of quorum).
- Proposal to authorize meeting adjournment passed with 33.7M for vs. 16.4M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326190/000132619025000050/0001326190-25-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326190/000132619025000050/alt-20250925x8k.htm
  HTML page:      https://secwatch.observer/filing/0001326190-25-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer